; and (2) make such database available on the public website of the Department of Health and Human Services. (b) Covered information The information relating to Federal support described in subsection (a)(1) includes all contracts, funding agreements, licensing arrangements, other transactions, and other arrangements entered into by, or on behalf of, the Federal Government and tax benefits provided with respect to research and development, and manufacturing, of a drug (including a biological product), cell or gene therapy, or medical device intended to be manufactured, used, designed, developed, modified, repurposed, licensed, or procured to diagnose, mitigate, prevent, treat, or cure any disease or condition, including the following: (1) Licensing agreements pursuant to section 207 or 209 of title 35, United States Code. (2) Cooperative research and development agreements and licensing agreements pursuant to section 12 of the Stevenson-Wydler Technology Innovation Act of 1980 ( 15 U.S.C. 3710a ). (3) Funding agreements, as defined in section 201 of title 35, United States Code. (4) Transactions, contracts, grants, cooperative agreements, other agreements, and other arrangements entered into pursuant to the following statutes: (A) The Public Health Service Act ( 42 U.S.C. 201 et seq. ), including sections 301, 319L, 421, and 480 of such Act ( 42 U.S.C. 241 , 247d–7e, 285b–3, 287a). (B) Section 105 of the National Institutes of Health Reform Act of 2006 ( 42 U.S.C. 284n ). (C) Chapter 301 of title 10, United States Code, including sections 4001, 4021, 4022, 4026, and 4023. (5) Grants, contracts, and other transactions pursuant to section 4021, 4022, or 4026 of title 10, United States Code. (6) Procurement contracts and other agreements pursuant to section 4023 of title 10, United States Code. (c) Information required Notwithstanding any other provision of law, the Federal officials described in subsection (a) shall include in the database under subsection (a), with regard to each contract, funding agreement,